Persistent Expansion And Th1-Like Skewing of HIV-Specific Circulating T Follicular Helper Cells During Antiretroviral Therapy

Products & Services
Catalog
- PepMix™ Peptide Pools
  PepMix™ Peptide Pools
  Pools of overlapping peptides from antigenic proteins for T-cell stimulation, T-cell expansion in T-cell assays such as ELISPOT, ICS or Flow Cytometry, e.g. for immune monitoring.
- Transduction Enhancer
  
  Transduction Enhancer
  Protransduzin™ the highly efficient transduction enhancer increases viral gene transfer in pre-clinical and clinical applications, such as ex vivo gene therapy and CAR-T cell development.
- Antigen Peptides
  - COVID-19 Antigen Peptides
  - Further Antigen Peptides
  Antigen Peptides
  Antigen peptides represent specific epitopes for stimulation of T cells in T cell assays such as ELISPOT. We offer the corresponding MHC multimer for each antigen peptide. Antigens from different pathogens are available as well as tumor associated antigens.
- MHC Multimers
  MHC Multimers
  MHC Multimers for reproducible detection, enumeration and isolation of antigen-specific T cells with disease specific peptides.
- Proteomics Peptides & Kits
  Proteomics Peptides & Kits
  Peptide sets and pools, as well as assay standardization kits are available with stable isotope labeled or unlabeled proteotypic peptides for mass-spectrometry based proteomics such as MRM assays.
- RepliTope™ Peptide Microarrays
  RepliTope™ Peptide Microarrays
  Peptide microarrays that display overlapping peptide scans through antigens from infectious organisms or tumor associated antigens for antibody or serum profiling.
- Chelate Peptides (DOTA)
  
  Chelate Peptides (DOTA)
  DOTA is linked to molecules that have affinity for various structures (e.g. somatostatin receptors in neuroendocrine tumors). The resulting compounds can be bound to radionuclided and are used with a number of radioisotopes in cancer therapy and diagnosis
- Cosmetic Peptides (DPRA Peptides)
  
  Cosmetic Peptides
  Cosmetic Peptides such as Lysine and Cysteine Peptide are used for DPRA (Direct Peptide Reactivity Assay) for Skin Sensitization Testing. The DPRA measures the reaction of a chemical with synthetic peptides containing Cysteine (Ac‑RFAACAA‑COOH) or Lysine (Ac‑RFAAKAA‑COOH) to assess its sensitization potency. For research use only!
- Immunology Standards & Controls
  - Control Peptide Pools
  - TERS Reference Samples
  Immunology Standards & Controls
  Standards and controls for reproducible T-cell assays such as ELISPOT and multimer assays. We offer a large variety of positive and negative control peptide pools for antigen specific T cell stimulation as well as kit to produce TCR-engineered reference samples for performance control.
- Abeta & Prion Peptides
  - Amyloid Beta A4 Peptides
  - Major Prion Peptides
  Abeta & Prion Peptides
  Purified, fully analyzed, high quality peptides, synthesized from the peptide experts for Alzheimers and prion research.
- Assay Services
  
  Assay Services
  We offer our extensive know-how and experience in peptide microarray incubation & data evaluation as full-service packages for many applications.
- Enzyme Substrates
  Enzyme Substrates
  Large collections of peptidic enzyme substrates in microtiter plates or displayed on microarrays for screening and enyzme profiling.
- Histone Peptide Tools
  Histone Peptide Tools
  Our histone peptide library is the largest on the market and available as Peptide ELISA, Peptide Microarray or sets of histone peptides
Contract Research
Company
- - JPT has a work force of >100 highly trained and skilled employees. 30 of our co-workers hold a university degree and 20 have a PhD in natural sciences.
News & Publications
Support & Contact
- - We take pride in our competent service and swift response. Please do not hesitate to contact us for further information. We also very much welcome your feedback and comments.

Persistent Expansion And Th1-Like Skewing of HIV-Specific Circulating T Follicular Helper Cells During Antiretroviral Therapy

Julia Niessl Wu et.al., EBioMedicine (2020) - PMID: 32268275

Product(s) used in this publication: PepMix™ Peptide Pools

Abstract

BACKGROUND:

Untreated HIV infection leads to alterations in HIV-specific CD4⁺ T cells including increased expression of co-inhibitory receptors (IRs) and skewing toward a T follicular helper cell (Tfh) signature. However, which changes are maintained after suppression of viral replication with antiretroviral therapy (ART) is poorly known.

METHODS:

We analyzed blood CD4⁺ T cells specific to HIV and comparative viral antigens in ART-treated people using a cytokine-independent activation-induced marker assay alone or in combination with functional readouts.

FINDINGS:

In intra-individual comparisons, HIV-specific CD4⁺ T cells were characterized by a larger fraction of circulating Tfh (cTfh) cells than CMV- and HBV-specific cells and preferentially expressed multiple IRs and showed elevated production of the Tfh cytokines CXCL13 and IL-21. In addition, HIV-specific cTfh exhibited a predominant Th1-like phenotype and function when compared to cTfh of other specificities, contrasting with a reduction in Th1-functions in HIV-specific non-cTfh. Using longitudinal samples, we demonstrate that this distinct HIV-specific cTfh profile was induced during chronic untreated HIV infection, persisted on ART and correlated with the translation-competent HIV reservoir but not with the total HIV DNA reservoir.

INTERPRETATION:

Expansion and altered features of HIV-specific cTfh cells are maintained during ART and may be driven by persistent HIV antigen expression.

FUNDING:

This work was supported by the National Institutes of Health (NIH), the Canadian Institutes of Health Research (CIHR) and the FRQS AIDS and Infectious Diseases Network.

Search

All Our Publications